Peter J Grant
Overview
Explore the profile of Peter J Grant including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
143
Citations
5363
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Handelsman Y, Anderson J, Bakris G, Ballantyne C, Bhatt D, Bloomgarden Z, et al.
Metabolism
. 2024 Jun;
159:155931.
PMID: 38852020
The spectrum of cardiorenal and metabolic diseases comprises many disorders, including obesity, type 2 diabetes (T2D), chronic kidney disease (CKD), atherosclerotic cardiovascular disease (ASCVD), heart failure (HF), dyslipidemias, hypertension, and...
2.
Gierula J, Straw S, Cole C, Lowry J, Paton M, McGinlay M, et al.
Diab Vasc Dis Res
. 2024 Apr;
21(2):14791641231224241.
PMID: 38623877
Introduction: Type 2 diabetes is a common and adverse prognostic co-morbidity for patients with heart failure with reduced ejection fraction (HFrEF). The effect of diabetes on long-term outcomes for heart...
3.
Rizza S, Luzi A, Mavilio M, Ballanti M, Massimi A, Porzio O, et al.
Acta Diabetol
. 2022 Aug;
59(12):1589-1596.
PMID: 36044097
Aims: Disturbances in circadian rhythms may promote cardiometabolic disorders in rotating night shift workers (r-NSWs). We hypothesized that timed light therapy might reverse disrupted circadian rhythms and glucose intolerance observed...
4.
Gierula J, Cole C, Drozd M, Lowry J, Straw S, A Slater T, et al.
ESC Heart Fail
. 2022 Jul;
9(5):3254-3263.
PMID: 35790085
Aims: Understanding of the pathophysiology of progressive heart failure (HF) in patients with heart failure with preserved ejection fraction (HFpEF) is incomplete. We sought to identify factors differentially associated with...
5.
Parker W, Sagar R, Kurdee Z, Hawkins F, Naseem K, Grant P, et al.
Cardiovasc Diabetol
. 2021 Dec;
20(1):238.
PMID: 34920734
Background: The enhanced thrombotic milieu in diabetes contributes to increased risk of vascular events. Aspirin, a key antiplatelet agent, has inconsistent effects on outcomes in diabetes and the best dosing...
6.
Odutayo A, da Costa B, Pereira T, Garg V, Iskander S, Roble F, et al.
J Am Heart Assoc
. 2021 Sep;
10(18):e019918.
PMID: 34514812
Background This study aimed to assess the effectiveness of sodium-glucose cotransporter 2 inhibitors in reducing the incidence of mortality and cardiovascular outcomes in adults with type 2 diabetes. Methods and...
7.
Rizza S, Luzi A, Mavilio M, Ballanti M, Massimi A, Porzio O, et al.
Acta Diabetol
. 2021 Mar;
58(8):1111-1117.
PMID: 33788000
Objective: To detect premature gluco-metabolic defects among night shift workers with disturbances in circadian rhythms. Design And Methods: We performed a hypothesis-generating, cross-sectional analysis of anthropometric, metabolic, lipid, and inflammation...
8.
Hannemann J, Laing A, Middleton B, Cridland J, Staels B, Marx N, et al.
J Hypertens
. 2021 Mar;
39(8):1678-1688.
PMID: 33710166
Objectives: Night shift work is associated with high rates of hypertension and cardiometabolic disease, which are linked to disrupted circadian rhythms. We hypothesized that timed light therapy might improve disrupted...
9.
Marx N, Davies M, Grant P, Mathieu C, Petrie J, Cosentino F, et al.
Lancet Diabetes Endocrinol
. 2021 Feb;
9(3):139-140.
PMID: 33607039
No abstract available.
10.
Grant P, Marx N
Eur Heart J Acute Cardiovasc Care
. 2020 Nov;
9(6):586-588.
PMID: 33203234
No abstract available.